Maintaining Immunity After Immunization (U01 - Clinical Trial Optional)

The summary for the Maintaining Immunity After Immunization (U01 - Clinical Trial Optional) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Maintaining Immunity After Immunization (U01 - Clinical Trial Optional): The goal of this Funding Opportunity Announcement (FOA) is to improve understanding of how durable protective immunity is achieved by supporting studies that define components and mechanisms of the immune system. Applications proposing human cells/tissue response studies will help determine the human responses elicited by immunization, however, animal studies may also be used to extend the findings from human tissues to more mechanistic studies not easily accomplished in humans.
Federal Grant Title: Maintaining Immunity After Immunization (U01 - Clinical Trial Optional)
Federal Agency Name: National Institutes of Health (HHS-NIH11)
Grant Categories: Health
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-AI-17-034
Type of Funding: Cooperative Agreement
CFDA Numbers: 93.855
CFDA Descriptions: Information not provided
Current Application Deadline: February 21st, 2018
Original Application Deadline: February 21st, 2018
Posted Date: October 20th, 2017
Creation Date: October 20th, 2017
Archive Date: March 29th, 2018
Total Program Funding: $6,400,000
Maximum Federal Grant Award: $450,000
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Last Updated: October 20th, 2017
Applicants Eligible for this Grant
State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For-profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification.)
Additional Information on Eligibility
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Link to Full Grant Announcement
http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-17-034.html
Grant Announcement Contact
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Similar Government Grants
Leadership Group for a Clinical Research Network on Antibacterial Resistance (UM1 Clinical...
Halting TB Transmission in HIV-Endemic and Other High-Transmission Settings (R01 Clinical ...
Elucidating the Functional Roles of Non-Coding RNAs in Viral Infectious Diseases (R21 Clin...
Advancing mAbs to Achieve a Drug-free Sustained HIV Virologic Remission (U01 Clinical Tria...
Global Infectious Disease Research Training Program (D43 Clinical Trial Optional)
Center for HIV/AIDS Vaccine Immunology (CHAVI)
Genomics of Transplantation Cooperative Research Program
Asthma and Allergic Diseases Cooperative Research Centers
More Grants from the National Institutes of Health
Time-Sensitive Obesity Policy and Program Evaluation (R01 Clinical Trial Not Allowed)
Encouraging Development of Novel Amelogenesis Models (UG3/UH3 Clinical Trial Not Allowed)
Drug Transport Across the Blood-Testis and Blood-Epididymal Barriers (R61/R33 - Clinical T...
Leadership Group for a Clinical Research Network on Antibacterial Resistance (UM1 Clinical...
Limited Competition: NIDCD National Temporal Bone, Hearing and Balance Pathology Resource ...

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2018 FederalGrants.com